Back
Return
Biography
Nalcioglu Orhan

Dr. Orhan Nalcioglu

University of California-Irvine, USA


Email: nalci@uci.edu


Qualifications

Founding Director, Univ. California-Irvine, USA

Professor, University of California, USA

Professor, Pusan University, South Korea

Adjunct Professor, Bogazici Universitesi, Turkey


Publications (Selected)

  1. Nie K, Chen J-H, Chang D, HsuC-C, NalciogluO, and Su M-Y (2009). “Quantitative Analysis of Breast Parenchymal Patterns Using 3D Fibroglandular Tissue Segmentation Based on MRI”. Med Phys 37(1): 217-226.
  2. NewellD, NieK, ChenJ-H, HsuC-C, YuHJ, NalciogluO, SuM-Y (2010). “Selection of Diagnostic Features to Differentiate between Malignant and Benign Lesions that Presented as Mass and Non-Mass Lesions on Breast MRI” Eur Radiol. 20(4): 771-81.
  3. Chen J-H, Nie K, Bahri S, Hsu C-C, Hsu F-T, Shih H-N, Lin M, Nalcioglu O, and Su M-Y (2010). “Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR imaging evaluation” Radiology 255(1): 44-52.
  4. Baek, H-M, Chen, J-H, Nalcioglu, O., Su, M-Y. (2010) “Can MR Spectroscopy Provide Useful Information for Characterizing Estrogen Receptor Status in Breast Cancer?” Ann. Onc. 21(3): 663-5.
  5. Hamamura MJ, Ha S-H, Roeck WW, Muftuler LT, Wagenaar DJ, Meier D, Patt BE, and Nalcioglu O (2010). “Development of an MR-compatible SPECT system (MRSPECT) for simultaneous data acquisition”. Phys Med Bio 55(6): p. 1563-75.
  6. Hamamura MJ, Ha S-H, Roeck WW, Wagenaar DJ, Meier D, Patt BE, and Nalcioglu O (2010) “Initial Investigation of Preclinical Integrated SPECT and MR Imaging” TCRT 9(1): 21-28.
  7. Barber WC, Lin Y, Nalcioglu O, Iwanczyk JS, Hartsough NE, and Gulsen G (2010) “Combined Fluorescence and X-Ray Tomography for Quantitative In Vivo Preclinical Cell Detection” TCRT 9(1): 45-52.
  8. Thayer D, Unlu MB, Lin Y, Yan K, Nalcioglu O, and Gulsen G (2010) “Dual-Contrast Dynamic MRI-DOT for Small Animal Imaging” TCRT 9(1): 61-70.
  9. Chen JH, Nalcioglu O, and Su MY (2010). “Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy” Ann Surg Oncol. 17(7): 1964-5.
  10. HaS-H, Hamamura MJ, Roeck WW, Muftuler LT, and Nalcioglu O (2010). “Development of a new RF coil and γ-ray radiation shielding assembly for improved MR image quality in SPECT/MRI” Phys in Med and Bio 55(9): 2495-2504.
  11. Lin Y, Barber WC, Iwanczyk JS, Roeck WW, Nalcioglu O, and Gulsen G (2010). “Quantitative Fluorescence Tomography Using a Tri-modality FT/DOT/XCT System: In vivo Validation” Optics Express 18(8): 7835–7850.
  12. Dubé C, Ravizza T, Hamamura M, Zha Q, Keebaugh A, Fok K, Andres A, Nalcioglu O, Obenaus A, Vezzani A, and Baram T (2010) “Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers”. J Neuroscience 30(22): 7484-94.
  13. Chen J-H, Nie K, Bahri S, Hsu C-C, Hsu F-T, Shih H-N, Lin M, Nalcioglu O, and Su M-Y (2010) “Decrease in Breast density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy” Radiology 255(1): 44-52.
  14. Shih T-C, Chen J-H, Liu D, Nie K, Sun L, Chang D, Nalcioglu O, Su M-Y (2010) “Computational Simulation of Breast Compression Based on Segmented Breast and Fibroglandular Tissues on Magnetic Resonance Images” Phys Med Biol. 55(14): 4153-68.
  15. Nie K, Su M-Y, Chau M-K, Chan S, Tseng T, Nguyen H, McLaren CE, Nalcioglu O, and Chen J-H (2010) “Age- and Race- Dependence of the Fibroglandular Breast Density Analyzed on 3D MRI”. Med Phys. 37(6): 2770-6.
  16. Lin Y, Barber WC, Iwanczyk JS, Roeck WWR, Nalcioglu O, and Gulsen G (2010). “Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system”. Optics Express 18(8): 7835-50.
  17. Ha S-H, Hamamura MJ, Nalcioglu O, and Muftuler LT (2010) “PIN Diode Controlled Dual-Tuned MRI RF Coil and Phased Array for Multi Nuclear Imaging”. Phys in Med and Bio 55(9): 2495-2504.